Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Goodwill (2021 - 2025)

10x Genomics (TXG) has disclosed Goodwill for 5 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • Quarterly Goodwill changed 0.0% to $4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $4.5 million for FY2025, 0.0% changed from the prior year.
  • Goodwill hit $4.5 million in Q4 2025 for 10x Genomics, roughly flat from $4.5 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $4.5 million in Q1 2021 to a low of $4.5 million in Q1 2021.
  • Historically, Goodwill has averaged $4.5 million across 5 years, with a median of $4.5 million in 2021.
  • Biggest YoY gain for Goodwill was 0.0% in 2022; the steepest drop was 0.0% in 2022.
  • Year by year, Goodwill stood at $4.5 million in 2021, then changed by 0.0% to $4.5 million in 2022, then changed by 0.0% to $4.5 million in 2023, then changed by 0.0% to $4.5 million in 2024, then changed by 0.0% to $4.5 million in 2025.
  • Business Quant data shows Goodwill for TXG at $4.5 million in Q4 2025, $4.5 million in Q3 2025, and $4.5 million in Q2 2025.